BioCentury
ARTICLE | Management Tracks

Vir names Jennifer Towne CSO

Plus: Genentech’s Amit Mehta joins Dren Bio, and updates from Rapport, Mozart and Cognito

October 31, 2023 1:17 AM UTC

Vir Biotechnology Inc. (NASDAQ:VIR) hired Jennifer Towne as EVP and CSO as part of a strategic shift to viral-associated diseases and immune targeting under the leadership of new CEO Marianne de Backer. Towne was SVP, immunology discovery and external innovation at Janssen Pharmaceuticals, part of Johnson & Johnson (NYSE:JNJ). Her appointment is effective Nov. 6.

Cancer and autoimmune disease company Dren Bio Inc. hired Amit Mehta as COO and CBO. Mehta was VP, head of business development at Genentech Inc., where he held a series of roles over his nearly18-year tenure. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article